Cargando…

The U.S. drug policy landscape : insights and opportunities for improving the view /

Discussions about reducing the harms associated with drug use and antidrug policies are often politicized, infused with questionable data, and unproductive. This paper provides a nonpartisan primer that should be of interest to those who are new to the field of drug policy, as well as those who have...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autores Corporativos: Rand Corporation, RAND Drug Policy Research Center
Otros Autores: Kilmer, Beau
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Santa Monica, CA : Rand Corporation, 2012.
Colección:Occasional paper (Rand Corporation) ; OP-393.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000 a 4500
001 JSTOR_ocn809933411
003 OCoLC
005 20231005004200.0
006 m o d
007 cr cnu---unuuu
008 120914s2012 caud obt 000 0 eng d
040 |a DID  |b eng  |e pn  |c DID  |d DOS  |d E7B  |d COO  |d N$T  |d OCLCO  |d JSTOR  |d OCLCF  |d OCLCO  |d OCLCQ  |d VLB  |d YDXCP  |d MERUC  |d EBLCP  |d DEBSZ  |d OCLCQ  |d NKT  |d CUS  |d AZK  |d AGLDB  |d OCLCQ  |d COCUF  |d OCLCQ  |d ZCU  |d OCLCQ  |d JBG  |d OCLCQ  |d LND  |d U3W  |d LOA  |d VFL  |d VTS  |d ICG  |d AU@  |d OCLCO  |d ERL  |d OCLCQ  |d OCLCO  |d MERER  |d OCLCO  |d OCLCA  |d ICN  |d OCLCO  |d OCLCA  |d STF  |d TXR  |d DKC  |d OCLCO  |d CNTRU  |d OCLCQ  |d OCLCO  |d M8D  |d NJT  |d OCLCQ  |d OCLCA  |d OCLCQ  |d OCLCA  |d MOR  |d CCO  |d YDX  |d WRM  |d CEF  |d NRAMU  |d VT2  |d WYU  |d SFB  |d OCL  |d AJS  |d OCLCO  |d TXQ  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCQ  |d OCL  |d OCLCQ  |d OCLCO 
019 |a 817892819  |a 961531882  |a 962709973  |a 988437165  |a 1125520852 
020 |a 9780833077318  |q (electronic bk.) 
020 |a 0833077317  |q (electronic bk.) 
020 |a 9780833077332  |q (electronic bk.) 
020 |a 0833077333  |q (electronic bk.) 
020 |z 9780833076991 
020 |z 083307699X 
029 1 |a AU@  |b 000052914928 
029 1 |a DEBBG  |b BV042970039 
029 1 |a DEBBG  |b BV044169022 
029 1 |a DEBSZ  |b 397400985 
029 1 |a DEBSZ  |b 423757474 
029 1 |a GBVCP  |b 1008657654 
029 1 |a GBVCP  |b 79944457X 
029 1 |a NZ1  |b 15025564 
029 1 |a AU@  |b 000055216883 
035 |a (OCoLC)809933411  |z (OCoLC)817892819  |z (OCoLC)961531882  |z (OCoLC)962709973  |z (OCoLC)988437165  |z (OCoLC)1125520852 
037 |a 22573/ctt12f21s  |b JSTOR 
043 |a n-us--- 
050 4 |a HV5825  |b .U135 2012eb 
060 4 |a 2013 A-549 
060 4 |a WM 33 AA1 
072 7 |a BUS  |x 032000  |2 bisacsh 
072 7 |a SOC  |x 000000  |2 bisacsh 
072 7 |a POL029000  |2 bisacsh 
072 7 |a LAW039000  |2 bisacsh 
072 7 |a SEL013000  |2 bisacsh 
082 0 4 |a 363.450973  |2 23 
088 |a RAND OP393 
049 |a UAMI 
245 0 4 |a The U.S. drug policy landscape :  |b insights and opportunities for improving the view /  |c Beau Kilmer [and others]. 
246 3 |a US drug policy landscape 
246 3 |a United States drug policy landscape 
260 |a Santa Monica, CA :  |b Rand Corporation,  |c 2012. 
300 |a 1 online resource (xiv, 51 pages) :  |b charts 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a data file 
490 1 |a RAND Corporation occasional paper series ;  |v OP393 
504 |a Includes bibliographical references (pages 41-51). 
520 |a Discussions about reducing the harms associated with drug use and antidrug policies are often politicized, infused with questionable data, and unproductive. This paper provides a nonpartisan primer that should be of interest to those who are new to the field of drug policy, as well as those who have been working in the trenches. It begins with an overview of problems and policies related to illegal drugs in the United States, including the nonmedical use of prescription drugs. It then discusses the efficacy of U.S. drug policies and programs, including long-standing issues that deserve additional attention. Next, the paper lists the major funders of research and analysis in the area and describes their priorities. By highlighting the issues that receive most of the funding, this discussion identifies where gaps remain. Comparing these needs, old and new, to the current funding patterns suggests eight opportunities to improve understanding of drug problems and drug policies in the United States: (1) sponsor young scholars and strengthen the infrastructure of the field, (2) accelerate the diffusion of good ideas and reliable information to decision-makers, (3) replicate and evaluate cutting-edge programs in an expedited fashion, (4) support nonpartisan research on marijuana policy, (5) investigate ways to reduce drug-related violence in Mexico and Central America, (6) improve understanding of the markets for diverted pharmaceuticals, (7) help build and sustain comprehensive community prevention efforts, and (8) develop more sensible sentencing policies that reduce the excessive levels of incarceration for drug offenses and address the extreme racial disparities. The document offers some specific suggestions for researchers and potential research funders in each of the eight areas. 
536 |a "This research was sponsored by the John D. and Catherine T. MacArthur Foundation ..." 
500 |a Title from PDF title screen (viewed on September 14, 2012). 
505 0 0 |g Introduction --  |t The drug policy landscape in the United States --  |t Efficacy of U.S. drug policies and programs --  |t The drug policy research funding landscape --  |t Opportunities to influence the drug policy field --  |g Concluding thoughts. 
546 |a English. 
590 |a JSTOR  |b Books at JSTOR Open Access 
590 |a JSTOR  |b Books at JSTOR All Purchased 
650 0 |a Drug control  |z United States. 
650 0 |a Drug abuse  |x Government policy  |z United States. 
650 0 |a Medical care. 
650 0 |a Health services administration. 
650 0 |a Organization. 
650 0 |a Social control. 
650 0 |a Social sciences. 
650 0 |a Sociology. 
650 2 |a Anthropology, Education, Sociology and Social Phenomena 
650 2 |a Delivery of Health Care 
650 2 |a Drug and Narcotic Control 
650 2 |a Health Care Economics and Organizations 
650 2 |a Health Services Administration 
650 2 |a Legislation as Topic 
650 2 |a Legislation, Drug 
650 2 |a Organization and Administration 
650 2 |a Pharmacy Administration 
650 2 |a Policy 
650 2 |a Public Policy 
650 2 |a Social Control Policies 
650 2 |a Social Control, Formal 
650 2 |a Social Sciences 
650 2 |a Sociology 
650 2 |a Patient Care 
650 6 |a Lutte antidrogue  |z États-Unis. 
650 6 |a Toxicomanie  |x Politique gouvernementale  |z États-Unis. 
650 6 |a Prestation de soins. 
650 6 |a Services de santé  |x Administration. 
650 6 |a Organisation. 
650 6 |a Contrôle social. 
650 6 |a Sciences sociales. 
650 6 |a Sociologie. 
650 6 |a Soins médicaux. 
650 7 |a social sciences.  |2 aat 
650 7 |a sociology.  |2 aat 
650 7 |a BUSINESS & ECONOMICS  |x Infrastructure.  |2 bisacsh 
650 7 |a SOCIAL SCIENCE  |x General.  |2 bisacsh 
650 7 |a POLITICAL SCIENCE  |x Public Policy  |x Social Policy.  |2 bisacsh 
650 7 |a Sociology  |2 fast 
650 7 |a Social sciences  |2 fast 
650 7 |a Social control  |2 fast 
650 7 |a Organization  |2 fast 
650 7 |a Medical care  |2 fast 
650 7 |a Health services administration  |2 fast 
650 7 |a Drug abuse  |x Government policy  |2 fast 
650 7 |a Drug control  |2 fast 
651 7 |a United States  |2 fast 
650 7 |a Drogenpolitik  |2 gnd 
651 7 |a USA  |2 gnd 
700 1 |a Kilmer, Beau. 
710 2 |a Rand Corporation. 
710 2 |a RAND Drug Policy Research Center. 
776 0 8 |i Print version:  |a Kilmer, Beau.  |t U.S. Drug Policy Landscape : Insights and Opportunities for Improving the View.  |d Santa Monica : RAND Corporation, ©2012  |z 9780833076991 
830 0 |a Occasional paper (Rand Corporation) ;  |v OP-393. 
856 4 0 |u https://jstor.uam.elogim.com/stable/10.7249/j.ctt1q60vs  |z Texto completo 
938 |a ProQuest Ebook Central  |b EBLB  |n EBL1047426 
938 |a ebrary  |b EBRY  |n ebr10678762 
938 |a EBSCOhost  |b EBSC  |n 490461 
938 |a YBP Library Services  |b YANK  |n 10887291 
938 |a YBP Library Services  |b YANK  |n 9892433 
994 |a 92  |b IZTAP